Adenomyosis: A Structured Integrative Approach to Diagnosis, Treatment and Fertility Planning
2026-04-20 17:47
Adenomyosis is often reduced to “heavy and painful periods”. In practice, it is a complex uterine disorder involving structural changes, hormonal signalling, inflammation and vascular activity, with variable effects on pain, bleeding and fertility.
This explains why patients present very differently — and why standard, uniform treatment pathways often fail.
Why I use a structured approach
In many cases, management becomes:
repeated hormonal changes
trial-and-error treatment
delayed or unclear fertility decisions
This is not due to lack of options, but lack of structure.
My approach is therefore built around a defined clinical framework (STRATA) to organise complexity and guide decision-making.
Step 1: Deep diagnostic mapping
The starting point is not simply confirming adenomyosis, but defining its architecture and behaviour.
This includes:
detailed clinical history (bleeding pattern, pain, reproductive history)
advanced transvaginal ultrasound (including junctional zone assessment where relevant)
MRI in selected cases for complex mapping or fertility planning
The aim is to define:
focal vs diffuse disease
depth and distribution
coexisting pathology (fibroids, endometriosis)
likely impact on symptoms and fertility
Step 2: Aligning with reproductive intent
Management is always built around:
symptom burden
disease pattern
reproductive goals
These may include:
symptom control only
active fertility planning
fertility preservation
This alignment is essential. Without it, treatment decisions are often inconsistent or inappropriate.
Step 3: A layered treatment architecture
Treatment is not a single intervention, but a structured sequence.
Hormonal layer
Used where appropriate to control bleeding and pain or modulate disease activity:
LNG-IUS
oral progestins
short-term GnRH-based suppression in selected cases
These are used within a defined plan, not indefinitely.
Structural consideration (external referral where appropriate)
In some patients, particularly with significant disease burden, structural intervention may be relevant.
This may include uterus-preserving options such as:
focused ultrasound
embolisation
or conservative surgical approaches
Where appropriate, patients are guided towards specialist centres for these options.
Integrative layer (system-level modulation)
Adenomyosis is not purely structural.
Within a structured plan, I also assess:
inflammatory activity
vascular function
metabolic influences
pain processing
Targeted adjunctive strategies may be used to support:
symptom control
treatment response
and endometrial environment
These are always:
evidence-informed
time-bound
and monitored against objective outcomes
Step 4: Fertility strategy is integrated from the start
Adenomyosis can affect implantation and pregnancy outcomes.
For women planning pregnancy:
imaging findings are used to assess risk
pre-conception optimisation may be required
timing of fertility treatment is planned strategically
Where IVF is involved, structured preparation may improve outcomes.
Step 5: A defined 6–12 month plan
Management is not open-ended.
A typical pathway includes:
baseline assessment (symptoms + imaging)
a staged plan over 6–12 months
predefined checkpoints
clear criteria for response or change in strategy
This replaces:
fragmented care
repeated short-term trials
delayed escalation
What this approach changes
Instead of:
uncertainty
repeated treatment changes
or late decisions
Patients receive:
structured understanding
prioritised actions
and a clear clinical direction
Conclusion
Adenomyosis requires more than symptom control.
It requires structured assessment, integrative thinking, and precise timing of interventions.
For a full explanation of my structured approach, including diagnostic mapping and treatment planning, see: